Strategia DIVA w zwalczaniu chorob zakaznych zwierzat

• Autorzy: Szweda W

Warianty tytułu

EN

DIVA strategy in the eradication of infectious diseases of animals

• Języki publikacji: PL

Abstrakty

EN

The article discusses the essence, purposes, methods of realizing and benefits of applying DIVA (Differentiating Infected from Vaccinated Animals) strategy for the eradication of infectious diseases of animals. Various types of marker vaccines and compatible serological tests suitable for use in this strategy are characterized. The article presents possibilities, principles, results and perspectives of applying DIVA strategy to eradicate Aujeszky«s disease, infectious bovine rhinotracheitis, classical swine fever, bovine viral diarrhoea and mucosal disease, foot and mouth disease, avian influenza, porcine parvovirus infection, bluetongue, equine influenza and African horse sickness. Through the application of marker vaccines which enable differentiation between infected and vaccinated animals as well as detection of asymptomatic carriers and shedders, DIVA strategy makes it possible to rid the population of many dangerous pathogens causing epizootics and panzootics. In appreciating the considerable importance of modern marker vaccines in the comprehensive eradication programmes for infectious diseases, this strategy not only considerably reduces economic losses and restores possibilities of international trade in animals and animal products, but also constitutes an alternative to the extremely expensive and sometimes strongly criticized administrative eradication method. That is why DIVA strategy should be more and more often applied for the eradication of infectious diseases in animals, but some of its elements, concerning mainly vaccine evaluation and the monitoring of infections in vaccinated and non-vaccinated groups of people, could also be utilized in public health protection.

Słowa kluczowe

PL

choroby zwierzat; choroby zakazne; zwalczanie chorob zwierzat; szczepienia ochronne; strategia DIVA; szczepionki delecyjne; szczepionki podjednostkowe; szczepionki wektorowe; szczepionki inaktywowane

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2009
• Tom: 65
• Numer: 06
• Opis fizyczny: s.373-376,bibliogr.

Twórcy

autor

Szweda W

• Uniwersytet Warminsko-Mazurski w Olsztynie, ul.Oczapowskiego 13, 10-719 Olsztyn

Bibliografia

• 1.Anderson J., Martens P. P. C., Herniman K. A. J.: A competitive ELISA for the detection of anti-tubule antibodies using a monoclonal antibody against Bluetonque virus non-structural protein NS1. J. Virol. Methods 1993, 43, 167-176.
• 2.Beer M., Reimann I., Hoffmann B., Depner K.: Novel marker vaccines against classical swine fever. Vaccine 2007, 25, 5665-5670.
• 3.Berger H. G., Straub O., Ahl R., Tesar M., Marquardt O.: Identification of foot-and-mouth disease virus replication in vaccinated cattle by antibodies to non-structural proteins. Vaccine 1990, 8, 213-216.
• 4.Birch-Machin I., Rowan A., Pick J., Mumford J., Binns M.: Expression of the non-structural protein NS1 of equine influenza A virus: detection of anti-NS1 antibody in post infection equine sera. J. Virol. Methods 1997, 65, 255-263.
• 5.Bosch J. C., de Jong M. C., Franken P., Frankena K., Hage J. J., Kaashoek M. J., Maris-Veldhuijs M. A., Noordhuizen J. P., van der Poel W. H., Verhoeff J., Weerdmeester K., Zimmer G. M., van Oirschot J. T.: An inactivated gE-negative marker vaccine and an experimental gD-subunit vaccine reduce the incidence of bovine herpesvirus 1 infections in the field. Vaccine 1998, 16, 265-271.
• 6.Bougrine S. J., Fehri O. F., Fehri M. M.: Western immunoblotting as a method for the detection of African horse sickness virus protein-specific antibodies: differentiation between infected and vaccinated horses. Arch. Virol. Suppl. 1998, 14, 329-336.
• 7.Bruschke C. J. M., Moormann R. J. M., van Oirschot J. T., van Rijn P. A.: A subunit vaccine based on glycoprotein E2 of bovine viral diarrhea virus induces fetal protection in sheep against homologous challenge. Vaccine 1997, 15, 1940-1945.
• 8.Capua I., Terregino C., Cattoli G., Mutinelli F., Rodriquez J. F.: Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza. Avian Pathol. 2003, 32, 47-55.
• 9.Cohen M. L.: Changing patterns of infectious diseases. Nature 2000, 406, 762-767.
• 10.Diego M. de, Brocchi E., Mackay D., de Simone F.: The non-structural polyprotein 3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle. Arch. Virol. 1997, 142, 2021-2033.
• 11.Drunen Littlel van -van den Hurk S.: Rationale and perspectives on the success of vaccination against bovine herpesvirus-1. Vet. Microbiol. 2006, 113, 275-282.
• 12.Floegel-Niesmann G.: Classical swine fever (CSF) marker vaccine. Trial III. Evaluation of discriminatory ELISA. Vet. Microbiol. 2001, 83, 121-136.
• 13.Harpin S., Talbot B., Mbikay M., Elazhary Y.: Immune response to vaccination with DNA encoding the bovine viral diarrhea virus major glycoprotein gp53 (E2). FEMS Microbiol. Lett. 1997, 146, 229-234.
• 14.Kaashoek M. J., Moerman A., Medic J. A., Weerdmeester K., Maris-Veldhuis M. A., Rijsewijk F. A. M., van Oirschot J. T.: An inactivated vaccine based on a glycoprotein gE-negative strain of bovine herpesvirus 1 induces protective immunity and allows serological differentiation. Vaccine 1995, 13, 342-346.
• 15.Kit S.: Genetically engineered vaccines for control of Aujeszky's disease (pseudorabies). Vaccine 1990, 8, 420-424.
• 16.Kita J.: O ciągłości chorób zakaźnych, czyli dawne i nowe epidemie-epizootie. Medycyna Wet. 1994, 50, 529-533.
• 17.Mackay D. K. J., Forsyth M. A., Davies P. R., Berlinzani A., Belsham G. J., Flint M., Ryan M. D.: Differentiating infection from vaccination in foot-and-mouth disease using a panel of recombinant, non-structural proteins in ELISA. Vaccine 1998, 16, 446-459.
• 18.Mackay D. K. J.: Differentiating infection from vaccination in foot-and-mouth disease. Vet. Quart. 1998, 20, 20-24.
• 19.Makoschey B., Sonnemans D., Munoz Bielasa J., Franken P., Mars M., Santos S., Alvarez M.: Ein inaktivierter Impstoff gegen die Bovine Virusdiarrhoe (BVD) hat Eigenschaften einer Markervakzine. 6. Stendaler Symposium zur BHV-1, BVD- und Paratuberculose-Bekämpftung. Stendal 2007, s. 56.
• 20.Mulder W. A. M., Pol J. M. A., Gruys E., Jacobs L., De Jong M. C. M., Peeters B. P. M., Kimman T. G.: Pseudorabies virus infection in pigs. Role of viral proteins in virulence, pathogenesis and transmission. Vet. Res. 1997, 28, 1-17.
• 21.Nauwynck H. J.: Functional aspects of Aujeszky's disease (pseudorabies) viral proteins with relation to invasion, virulence and immunogenicity. Vet. Microbiol. 1997, 55, 3-11.
• 22.Niedbalski W., Kęsy A.: Serologiczne różnicowanie zwierząt szczepionych od zakażonych wirusem pryszczycy. Medycyna Wet. 2006, 62, 20-23.
• 23.Oirschot J. T. van: Diva vaccines that reduce virus transmission. J. Biotechnol. 1999, 73, 195-205.
• 24.Oirschot J. T. van: Marker vaccines (deleted or not, criteria for the choice of deletion, associated diagnostis reagents), [w:] Pastoret P. P. et al. (Eds): Veterinary Vaccinology. Elsevier Science B. V., Amsterdam, The Netherlands 1997, s. 267.
• 25.Oirschot J. T. van, Gielkens A. L. J., Moormann R. J. M., Berns A. J. M.: Marker vaccines, virus protein-specific assays and the control of Aujeszky's disease. Vet. Microbiol. 1990, 123, 85-101.
• 26.Oirschot J. T. van, Kaashoek M. J., Maris-Veldhuis M. A., Weerdmeester K., Rijsewijk F. A. M.: An enzyme-linked immunosorbent assay to detect antibodies against glycoprotein gE of bovine herpesvirus 1 allows differentiation between infected and vaccinated cattle. J. Virol. Methods 1997, 67, 23-34.
• 27.Oirschot J. T. van, Kaashoek M. J., Rijsewijk F. A. M., Stegeman J. A.: The use of marker vaccines in eradication of herpesviruses. J. Biotechnol. 1996, 44, 75-81.
• 28.Oirschot J. T. van, Rziha H. J., Moonen P. J. L. M., Pol J. M. A., van Zaane D.: Differentiation od serum antibodies from pigs vaccinated or infected with Aujeszky's disease virus by a competitive enzyme immunoassay. J. Gen. Virol. 1986, 67, 1179-1182.
• 29.Oirschot J. T. van, de Waal C. A. H.: An ELISA to distinguish between Aujeszky's disease vaccinated and infected pigs. First experience with its use in a vaccinated herd. Vet. Rec. 1987, 121, 305-306.
• 30.Quint W. G. V., Gielkens A. L. J., Berns A. J. M., van Oirschot J. T., Cuypers H. T.: Construction and characterization of deletion mutants of pseudorabies virus: a new generation of "live" vaccines. J. Gen. Virol. 1987, 68, 523-534.
• 31.Rijn P. A. van, van Gennip H. G., Moormann R. J.: An experimental marker vaccine and accompanying serological diagnostic test both based on envelope glycoprotein E2 of classical swine fever virus (CSFV). Vaccine 1999, 17, 433-440.
• 32.Smedegaard Madsen E., Madsen K. G., Nielsen J., Holm Jensen M., Lei J. C., Have P.: Detection of antibodies against porcine parvovirus nonstructural protein NS1 may distinguish between vaccinated and infected pigs. Vet. Microbiol. 1997, 54, 1-16.
• 33.Stegeman J. A.: Pseudorabies virus eradication by area-wide vaccination is feasible. Praca dokt., Utrecht University 1995.
• 34.Suarez D. L.: Overview of avian influenza DIVA test strategies. Biologicals 2005, 33, 221-226.
• 35.Szweda W., Lipowski A., Bączek W., Dadun M., Platt-Samoraj A., Siemionek J., Ciecierski H., Procajło Z.: Wyniki uwalniania ferm świń od wirusa choroby Aujeszky'ego po 5 latach stosowania programu "szczepienie-eliminacja". Medycyna Wet. 2000, 56, 386-391.
• 36.Szweda W., Lipowski A., Bączek W., Platt-Samoraj A., Siemionek J., Ciecierski H., Procajło Z.: Skuteczność programu "szczepienie-eliminacja" w utrzymywaniu statusu fermy œwiñ wolnej od wirusa choroby Aujeszky'ego. Medycyna Wet. 2000, 56, 447-451.
• 37.Szweda W., Lipowski A., Pejsak Z.: Strategia uwalniania pañstw Unii Europejskiej, w tym Polski, od choroby Aujeszky'ego. Medycyna Wet. 2004, 60, 1156-1160.
• 38.Truszczyński M., Pejsak Z.: Szczepionki nowej generacji. Medycyna Wet. 2006, 62, 855-859.
• 39.Tumpey T. M., Alvarez R., Swayne D. E., Suarez D. L.: Diagnostic approach for differentiating infected from vaccinated poultry on the basis of antibodies to NS1, the nonstructural protein of influenza A virus. J. Clin. Microbiol. 2005, 43, 676-683.
• 40.Wardley R. C., Post L. E.: The use of the gX deleted vaccine PRVΔTKΔgX-1 in the control of Aujeszky's disease, [w:] Oirschot J. T. van (Ed.): Vaccination and Control of Aujeszky's Disease, ECSC, EEC, EAEC. Brussels and Luxembourg 1989, s. 13.